Redx Pharma Plc
PrivateLast Round
Series A
Aug 14, 2026
Est. Valuation
$214.65M
Total Funding Raised
$29M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Redx Pharma Plc operates in Healthcare & Life Sciences and is based in Macclesfield. Its latest recorded funding round was a Private Placement round in October 2023.
Redx Pharma Plc is a clinical-stage biotechnology company that discovers and develops novel, small molecule, targeted medicines for the treatment of fibrotic disease and cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Redx Pharma Plc Comparables
Compare Redx Pharma Plc with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Graviton BioScience | 85% | |
| Pliant Therapeutics | 79% | |
| Endeavor BioMedicines | 78% |
For institutional investors. Book with your work email.
Redx Pharma Plc Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 14, 2026 | ||||
| Private Placement | Oct 18, 2023 | ||||
| Private Placement | May 19, 2022 | ||||
| Private Placement | Dec 2, 2020 | ||||
| Convertible Debt | Aug 4, 2020 | ||||
Private Placement | Jul 21, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Redx Pharma Plc Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redmile Group | Convertible Debt, Private Placement, Series A |
| Polar Capital | Private Placement |
| Platinum Asset Management | Private Placement |
| British Business Bank | Series A |
| Abingworth | Series A |
| Sofinnova Partners | Convertible Debt, Private Placement |
| Invus | Private Placement |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 14, 2026
$36M round led by Abingworth.
- Jan 21, 2026
Monthly visitors increased 50% MoM, reaching 6.6K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- has_lossSep 30, 2026
Redx Pharma Plc made losses of £18.4 million ($23.2M) for the 15-month period ended Dec 31st '25, following a change in its financial year-end, in United Kingdom.
- hiresSep 2, 2026
On Sep 2nd '26, Redx Pharma Plc appoints Dr Mei-Lun Wang as chief medical officer on a permanent basis, strengthening its clinical leadership and gastroenterology expertise in the United Kingdom.
For institutional investors. Book with your work email.
Redx Pharma Plc Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Redx Pharma Plc's valuation, stock price, and market status.
Is Redx Pharma Plc a public or private company?
Redx Pharma Plc is a private company.
What is the current stock price of Redx Pharma Plc?
Redx Pharma Plc is a private company, so its shares have no public market price. Caplight tracks Redx Pharma Plc's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Redx Pharma Plc worth (valuation)?
Redx Pharma Plc's valuation is estimated at $214.7M based on funding round data.
Can I buy Redx Pharma Plc stock?
Redx Pharma Plc shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Redx Pharma Plc's last funding round?
Redx Pharma Plc's most recent funding round was Series A on August 14, 2026.
Who are the main investors in Redx Pharma Plc?
Key investors in Redx Pharma Plc include Redmile Group, Abingworth, Sofinnova Partners.
Will Redx Pharma Plc IPO soon?
No public IPO plans have been announced for Redx Pharma Plc.
How can I track Redx Pharma Plc secondary market activity?
Caplight tracks bids, offers, and trades in Redx Pharma Plc's shares on secondary markets.